[1]赵彩琴,赵宝祥.新辅助放射治疗和化学治疗联合手术治疗晚期子宫内膜癌效果观察[J].新乡医学院学报,2019,36(1):074-76.[doi:10.7683/xxyxyxb.2019.01.016]
 ZHAO Cai-qin,ZHAO Bao-xiang.Effect of neoadjuvant radiotherapy and chemotherapy combined with surgery in the treatment of advanced endometrial carcinoma[J].Journal of Xinxiang Medical University,2019,36(1):074-76.[doi:10.7683/xxyxyxb.2019.01.016]
点击复制

新辅助放射治疗和化学治疗联合手术治疗晚期子宫内膜癌效果观察
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年1
页码:
074-76
栏目:
临床研究
出版日期:
2019-01-05

文章信息/Info

Title:
Effect of neoadjuvant radiotherapy and chemotherapy combined with surgery in the treatment of advanced endometrial carcinoma
作者:
赵彩琴1赵宝祥2
(1.南阳市第一人民医院生殖妇科,河南 南阳 473000;2.秦皇岛市第二医院检验科,河北 秦皇岛 066000)
Author(s):
ZHAO Cai-qin1ZHAO Bao-xiang2
(1.Department of Reproductive Medicine and Gynecology,the First People′s Hospital of Nanyang City,Nanyang 473000,Henan Province,China;2.Department of Clinical Laboratory,the Second Hospital of Qinhuangdao,Qinhuangdao 066000,Hebei Province,China)
关键词:
子宫内膜癌新辅助放射治疗新辅助化学治疗手术治疗
Keywords:
endometrial carcinomaneoadjuvant radiotherapyneoadjuvant chemotherapysurgical treatment
分类号:
R711
DOI:
10.7683/xxyxyxb.2019.01.016
文献标志码:
A
摘要:
目的 探讨新辅助放射治疗和化学治疗联合手术治疗晚期子宫内膜癌的临床效果。方法 选择2013年2月至2015年2月南阳市第一人民医院收治的98例晚期子宫内膜癌患者为研究对象,按照治疗方案分为对照组和观察组,每组49例。对照组患者给予手术治疗,观察组患者给予新辅助放射治疗、化学治疗联合手术治疗,2组患者术后均给予规范化学治疗。分别于治疗前及术后3个月采用世界卫生组织生存质量测定量表评估2组患者的生活质量;所有患者术后随访3 a,统计3 a生存率和无瘤生存时间。结果 治疗前观察组和对照组患者生活质量评分分别为39.75±5.16、39.19±5.84,术后3个月观察组和对照组患者生活质量评分分别为60.95±3.67、51.46±4.29;治疗前2组患者生活质量评分比较差异无统计学意义(t=0.503,P>0.05);2组患者术后3个月生活质量评分高于治疗前(t=21.225、11.853,P<0.05);术后3个月,观察组患者生活质量评分高于对照组(t=9.587,P<0.05)。观察组和对照组患者术后3 a生存率分别为63.27%(31/49)、46.94%(23/49),2组患者术后3 a生存率比较差异无统计学意义(χ2=2.640,P>0.05)。观察组和对照组患者无瘤生存时间分别为(24.19±3.18)、(20.06±2.19)个月,观察组患者无瘤生存时间长于对照组(t=7.491,P<0.05)。结论 新辅助放射治疗和化学治疗联合手术治疗可以显著延长晚期子宫内膜癌患者的无瘤生存时间,提高患者的生活质量。
Abstract:
Objective To investigate the clinical effect of neoadjuvant radiotherapy and chemotherapy combined with surgery in the treatment of advanced endometrial carcinoma.Methods Ninety-eight patients with advanced endometrial carcinoma in the First People′s Hospital of Nanyang City from February 2013 to February 2015 were selected as the subjects.The patients were divided into control group and observation group according to the treatment plan,forty-nine cases in each group.The patients in the control group were treated with surgery alone,while the patients in the observation group were treated with neo adjuvant radiotherapy and chemotherapy combined with surgery.The patients in the two groups were treated with standardized chemotherapy after operation.The quality of life of the patients in the two groups was assessed by World Health Organization quality of life scale before treatment and 3 months after operation.All patients were followed up for 3 years,and the 3-year survival rate and tumor-free survival time were counted.Results The score of quality of life in the observation group and the control group was 39.75±5.16 and 39.19±5.84 respectively before treatment.The score of quality of life in the observation group and the control group was 60.95±3.67 and 51.46±4.29,respectively at three months after operation.There was no significant difference in the score of quality of life between the two groups before treatment (t=0.503,P>0.05).The score of quality of life at 3 months after operation was higher than that before treatment in the two groups (t=21.225,11.853;P<0.05).The score of quality of life in the observation group was higher than that in the control group at three months after operation (t=9.587,P<0.05).The 3-year survival rate in the observation group and the control group was 63.27% (31/49) and 46.94% (23/49),respectively.There was no significant difference in the 3-year survival rate between the two groups (χ2=2.640,P>0.05).The tumor-free survival time in the observation group and the control group was 24.19±3.18 months and 20.06±2.19 months,respectively.The tumor-free survival time in the observation group was longer than that in the control group (t=7.491,P<0.05).Conclusion Neoadjuvant radiotherapy and chemotherapy combined with surgery can significantly prolong the tumor-free survival time,improve the quality of life of patients with advanced endometrial carcinoma.

参考文献/References:

[1] 房冰,王晶.年轻子宫内膜癌保留生育功能的研究进展[J].现代肿瘤医学,2013,21(6):1401-1404.
[2] 郭会敏,范毛川,华方方,等.脂联素对子宫内膜癌Ishikawa细胞增殖及侵袭和转移能力的影响[J].新乡医学院学报,2018,35(7):563-567.
[3] 谭莉萍,岑洪,胡晓桦.实体瘤疗效评价标准的历史、现状及其存在的问题[J].医学综述,2009,15(10):1492-1494.
[4] 郝元涛,方积乾,Power MJ,等.WHO生存质量评估简表的等价性评价[J].中国心理卫生杂志,2006,20(2):71-75.
[5] 刘若男,刘文静,邱建阁,等.牛蒡子苷元对子宫内膜癌 HEC-1B细胞的增殖抑制作用及机制[J].世界中医药,2018,13(8):2015-2018.
[6] 刘妮,闫雅欣,钱延玲,等.子宫内膜癌的治疗进展[J].医药前沿,2016,6(11):5-7.
[7] 公苓苓,郭杨,孙浩罡,等.子宫内膜癌的治疗进展[J].中国妇幼保健,2015,30(11):1797-1799.
[8] 刘健,崔艳艳,李胜泽,等.新辅助放化疗联合手术治疗ⅠB2~ⅡA2期子宫颈癌临床预后因素分析[J].中国癌症杂志,2016,26(5):427-433.
[9] 张利华,赵云,胡兵,等.子宫内膜癌放射治疗的研究进展[J].广东医学,2013,34(24):3830-3832.

相似文献/References:

[1]陈彩霞,赵孟军,李国芸.子宫内膜癌160例临床和手术病理分期比较[J].新乡医学院学报,2005,22(06):582.
 CHEN Caixia,ZI-UkO Mengjun,LI Guoyun.Comparison of clinical stage and operative pathological stage in 1 60 patients with endometrial cancer[J].Journal of Xinxiang Medical University,2005,22(1):582.
[2]周开梅,袁森辅,吴 晶,等.人附睾蛋白4和糖类抗原125在子宫内膜癌组织中的表达[J].新乡医学院学报,2018,35(3):219.[doi:10.7683/xxyxyxb.2018.03.015]
 ZHOU Kai-mei,YUAN Sen-fu,WU Jing,et al.Expression of human epididymis protein 4 and carbohydrate antigen 125 in endometrial carcinoma tissues[J].Journal of Xinxiang Medical University,2018,35(1):219.[doi:10.7683/xxyxyxb.2018.03.015]
[3]琚 莹,杨 君.MicroRNA-182和Ki-67在Ⅰ型和Ⅱ型子宫内膜癌组织中的表达[J].新乡医学院学报,2020,37(1):057.[doi:10.7683/xxyxyxb.2020.01.014]
 JU Ying,YANG Jun.Expression of microRNA-182 and Ki-67 in type Ⅰ and type Ⅱ endometrial carcinoma tissues[J].Journal of Xinxiang Medical University,2020,37(1):057.[doi:10.7683/xxyxyxb.2020.01.014]
[4]白云云,王世进,李 赟.血清人附睾蛋白4和糖类抗原125联合检测对子宫内膜癌淋巴结转移的诊断价值[J].新乡医学院学报,2021,38(8):725.[doi:10.7683/xxyxyxb.2021.08.005]
 BAI Yunyun,WANG Shijin,LI Yun.Diagnostic value of combined detection of serum human epididymal protein 4 and carbohydrate antigen 125 for lymph node metastasis in endometrial cancer[J].Journal of Xinxiang Medical University,2021,38(1):725.[doi:10.7683/xxyxyxb.2021.08.005]
[5]豆秋彦,冯 文,李春霖.脂肪因子chemerin在女性常见恶性肿瘤中的作用研究进展[J].新乡医学院学报,2020,37(12):1195.[doi:10.7683/xxyxyxb.2020.12.021]
[6]寇建芳,孟跃进.宫腔镜检查联合血清人附睾分泌蛋白及糖类抗原和miR-21早期诊断子宫内膜癌的临床价值[J].新乡医学院学报,2019,36(2):185.[doi:10.7683/xxyxyxb.2019.02.022]
 KOU Jian-fang,MENG Yue-jin.Clinical value of hysteroscopy combined with serum human epididymis protein 4,carbohydrate antigen 125 and miR-21 in early diagnosis of endometrial carcinoma[J].Journal of Xinxiang Medical University,2019,36(1):185.[doi:10.7683/xxyxyxb.2019.02.022]
[7]张 英,马瑞霞,杜艳云,等.MicroRNA-15b在子宫内膜癌组织中的表达及其对子宫内膜癌细胞增殖的影响[J].新乡医学院学报,2018,35(3):177.[doi:10.7683/xxyxyxb.2018.03.004]
 ZHANG Ying,MA Rui-xia,DU Yan-yun,et al.Expression of microRNA-15b in endometrial carcinoma and its effect on proliferation of endometrial carcinoma cells[J].Journal of Xinxiang Medical University,2018,35(1):177.[doi:10.7683/xxyxyxb.2018.03.004]
[8]郭会敏,范毛川,华方方,等.脂联素对子宫内膜癌Ishikawa细胞增殖及侵袭和转移能力的影响[J].新乡医学院学报,2018,35(7):563.[doi:10.7683/xxyxyxb.2018.07.004]
 GUO Hui-min,FAN Mao-chuan,HUA Fang-fang,et al.Effects of adiponectin on invasion and metastasis of endometrial carcinoma Ishikawa cells[J].Journal of Xinxiang Medical University,2018,35(1):563.[doi:10.7683/xxyxyxb.2018.07.004]
[9]徐 岚.大蒜素促进人子宫内膜癌细胞株HEC-1细胞凋亡的细胞外信号调节激酶信号通路研究[J].新乡医学院学报,2016,33(1):020.[doi:10.7683/xxyxyxb.2016.01.006]
 XU Lan.Study on the extracellular signal-regulated kinase signal pathway of allicin promoting apoptosis in human endometrial cancer HEC-1 cell strain[J].Journal of Xinxiang Medical University,2016,33(1):020.[doi:10.7683/xxyxyxb.2016.01.006]
[10]朱春霞,孟 勇,王秀虹.血清人附睾分泌蛋白4、糖类抗原125和脂联素在子宫内膜癌淋巴结转移诊断中的价值[J].新乡医学院学报,2016,33(5):403.[doi:10.7683/xxyxyxb.2016.05.016]
 ZHU Chun-xia,MENG Yong,WANG Xiu-hong.Value of serum human epididymis protein 4,carbohydrate antigen 125 and adiponectin in the diagnosis of lymphatic metastasis in patients with endometrial carcinoma[J].Journal of Xinxiang Medical University,2016,33(1):403.[doi:10.7683/xxyxyxb.2016.05.016]

更新日期/Last Update: 2019-01-05